Showing results (201-210 of 305) with videos related to
Sort By:
Pageof 31
Haematologica|December 31, 2011
Multiple myeloma shows no intra-disease clustering of immunoglobulin heavy chain genesSimone Ferrero, Daniela Capello, Mirija Svaldi, et al.Leukemia Research|August 23, 2005
Bortezomib (Velcade) for progressive myeloma after autologous stem cell transplantation and thalidomidePellegrino Musto, Antonietta Falcone, Grazia Sanpaolo, et al.Blood|March 19, 2021
Dose/schedule-adjusted Rd-R vs continuous Rd for elderly, intermediate-fit patients with newly diagnosed multiple myelomaAlessandra Larocca, Francesca Bonello, Gianluca Gaidano, et al.British Journal of Haematology|January 28, 2009
Reversibility of symptomatic peripheral neuropathy with bortezomib in the phase III APEX trial in relapsed multiple myeloma: impact of a dose-modification guidelinePaul G Richardson, Pieter Sonneveld, Michael W Schuster, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 14, 2010
Bortezomib-melphalan-prednisone-thalidomide followed by maintenance with bortezomib-thalidomide compared with bortezomib-melphalan-prednisone for initial treatment of multiple myeloma: a randomized controlled trialAntonio Palumbo, Sara Bringhen, Davide Rossi, et al.The Oncologist|January 21, 2010
Current multiple myeloma treatment strategies with novel agents: a European perspectiveHeinz Ludwig, Meral Beksac, Joan Bladé, et al.Leukemia|May 4, 2023
Management of patients with multiple myeloma and COVID-19 in the post pandemic era: a consensus paper from the European Myeloma Network (EMN)Evangelos Terpos, Pellegrino Musto, Monika Engelhardt, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 20, 2013
Transcriptional characterization of a prospective series of primary plasma cell leukemia revealed signatures associated with tumor progression and poorer outcomeKatia Todoerti, Luca Agnelli, Sonia Fabris, et al.Cancers|November 8, 2019
Lenalidomide Maintenance with or without Prednisone in Newly Diagnosed Myeloma Patients: A Pooled AnalysisFrancesca Bonello, Stefano Pulini, Stelvio Ballanti, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 30, 2021
Development and Validation of a Simplified Score to Predict Early Relapse in Newly Diagnosed Multiple Myeloma in a Pooled Dataset of 2,190 PatientsGian Maria Zaccaria, Luca Bertamini, Maria Teresa Petrucci, et al.Pageof 31